Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr Reddy's recalling over 8,000 bottles of generic drug in US due to a packaging error

Date: 08-01-2024

Dr Reddy's Laboratories is recalling over 8,000 bottles of a generic medication used to prevent rejection of a transplanted organ from the US market due to a packaging error. The Hyderabad-based drug major is recalling 8,280 bottles of Tacrolimus capsules from the US market for ‘presence of foreign tablets/capsules’ in the affected lot. One 0.5 mg Tacrolimus capsule was found in a bottle of 1 mg Tacrolimus capsules. The affected lot was produced at Dr Reddy's Bachupally-based plant near Hyderabad.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.